• An Image

    Our teams, facility and working environment are geared towards making the innovation faster, efficient and successful.

  • An Image

    As a drug discovery incubator, IBS is armed with experience, scientific tools, computer aided drug designing, expertise in chemistry, analytical instrumentation, in-vitro pharmacology and ADME.

  • An Image

    Dedicated teams include the best and brightest talent trained at Indian/International elite universities for which achieving the scientific goals is the sole priority.

Integral Biosciences (IBS) is a Delhi-based Indian biotech company, which operates on a hybrid business model.

IBS has capabilities to support medicinal chemistry, in-vitro screening and initial DMPK characterization of compounds...

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of Bruton’s Tyrosine Kinase and Phosphoinositide 3-Kinase p110δ, ACS Medicinal Chemistry Letters (2016).

Integral Biosciences (IBS) is a Delhi-based Indian biotech company, which operates a hybrid business model.

IBS has capabilities to support medicinal chemistry, in-vitro screening and initial DMPK characterization of compounds...

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of Bruton’s Tyrosine Kinase and Phosphoinositide 3-Kinase p110δ, ACS Medicinal Chemistry Letters (2016).